Thus, there are many studies focusing on the clinicopathological features and prognostic influence of maspin expression in various types of cancer, such as breast, lung, prostate, and pancreatic cancer; however, it remains controversial whether maspin expression is an unfavorable or favorable indicator in patients with several types of cancer14. This evidence concerns the gene SERPINB5 and pancreatic neoplasm.